Astellas Pharma Inc. (Jobs) Shares Fall On FDA News On Transplant Drug

January 24, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TOKYO, Jan 24 (Reuters) - Shares in Japan's Astellas Pharma Inc. tumbled nearly 5 percent on Wednesday after the U.S. authorities said it could not yet approve a new formulation of its immunosuppressant drug for heart transplant patients.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Asia